One challenge in vaccine growth is economic: Lots of the health conditions most demanding a vaccine, which include HIV, malaria and tuberculosis, exist principally in inadequate nations around the world. Pharmaceutical corporations and biotechnology corporations have very little incentive to develop vaccines for these diseases mainly because There